Latest filing published 07 Apr 2025 for NEUROONE MEDICAL TECHNOLOGIES Corp, €91k.
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Ronald W. McClurg is a declared insider of NEUROONE MEDICAL TECHNOLOGIES Corp (finance chief), with filings sourced from SEC (Form 4). We count 9 filings; the first trade dates from 3 February 2022 and the latest from 4 April 2025.
Every open-market trade on record is a purchase: 6 purchases worth €185k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 3 share grants. Since January 2025: 1 purchase and no sales on the market.
In size, the median ticket on the buying side is €14k. Of 6 purchases, 1 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
On 7 April 2025 came the latest disclosure, an open-market purchase for €91k in NEUROONE MEDICAL TECHNOLOGIES Corp. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations